CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
CERE
Delisted
CERE was delisted on the 31st of July, 2024.
124 hedge funds and large institutions have $4.23B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 54 increasing their positions, 27 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
12% more capital invested
Capital invested by funds: $3.78B → $4.23B (+$443M)
10% more funds holding
Funds holding: 113 → 124 (+11)
Holders
124
Holding in Top 10
3
Calls
$21.3M
Puts
$14.9M
Top Buyers
| 1 | +$22.2M | |
| 2 | +$11.3M | |
| 3 | +$9.27M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$8.2M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$7.93M |
Top Sellers
| 1 | -$50.9M | |
| 2 | -$21.5M | |
| 3 | -$14.1M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$5.03M |
| 5 |
Alkeon Capital Management
New York
|
-$3.29M |